Publication | Closed Access

YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models

AsthmaAllergyLung InflammationMedicineImmunologyAntigen-induced Airway EosinophiliaAnimal ModelsPulmonary PharmacologyEosinophilic DisorderPharmacologyTh2 Cytokine Inhibition